Why is Remus Pharma. falling/rising?

As of 10-Jul, Remus Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 878.55, which represents a decrease of 11.25 or 1.26%. The stock has underperformed significantly, with a one-week return of -9.30% and a one-month return of -10.28%. Additionally, it is trading lower than all its moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. The stock is also close to its 52-week low, being just 0.97% away from the low of Rs 870. Despite a rise in delivery volume by 61.87% against the 5-day average, there are no positive factors reported that could counterbalance the negative performance.
In the broader market context, the Sensex has shown a slight decline of only 0.20% over the past week, indicating that the broader market is not experiencing the same level of distress as Remus Pharmaceuticals. Year-to-date, while the stock has plummeted by 29.65%, the Sensex has gained 7.23%, highlighting a stark contrast in performance. This underperformance relative to the benchmark suggests that investor sentiment towards Remus Pharmaceuticals is particularly weak, contributing to the ongoing decline in its stock price.